Legal Opinion
Johnson v. GlaxoSmithKline, Inc.
California Court of Appeal
Decided September 19, 2008No. B199453PublishedCited by 37 opinions
1Opinion of the Court
Opinion
PERLUSS, P. J.
In two published decisions the United States District Court for the Central District of California denied class certification in putative class actions brought by current and former users of the prescription drug Paxil against GlaxoSmithKline, Inc. (GSK), the drug’s manufacturer, which alleged GSK had deceptively advertised Paxil as non-habit-forming. Relying upon those decisions and Alvarez v. May Dept. Stores Co. (2006) 143 Cal.App.4th 1223 [49 Cal.Rptr.3d 892] (Alvarez), which applied established principles of collateral estoppel to class certification issues, the…
2Cases cited39 opinions
- Amchem Products, Inc. v. WindsorSupreme Court of the United States · 1997
- Taylor v. SturgellSupreme Court of the United States · 2008
- Hansberry v. LeeSupreme Court of the United States · 1940
- Semtek International Inc. v. Lockheed Martin Corp.Supreme Court of the United States · 2001
- Lucido v. Superior CourtCalifornia Supreme Court · 1990
34 more not listed; retrieve them via the Exa API.
3Cited by37 opinions
- Daniels v. Select Portfolio Servicing, Inc.California Court of Appeal · 2016
- Mullins v. StateTennessee Supreme Court · 2009
- Cohen v. DirecTV, Inc.California Court of Appeal · 2009
- Association of Irritated Residents v. Department of ConservationCalifornia Court of Appeal · 2017
- Ivanoff v. Bank of America, N.A.California Court of Appeal · 2017
32 more not listed; retrieve them via the Exa API.